DESIGN, FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE TABLET FORMULATIONS OF LEVOSULPIRIDE

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 3

Abstract

Levosulpiride is a widely used gastroprokinetic agent in the treatment of various gastric disorders. It’s short half-life and increased dosage frequency leads to poor compliance and possible adverse effects. The prime objective of the current study was to develop a sustained release formulation of Levosulpiride by Direct compression method using polymers like Carboxymethyl cellulose sodium (CMC), Hydroxypropyl cellulose (HPC) and Hydroxypropylmethyl cellulose (HPMC) in varying concentrations. The prepared tablets were then evaluated for various physical parameters. The in-vitro absorbance was determined at a wavelength of 214nm using UV/Visible spectrophotometer and the data was analyzed using different kinetic models. The release profile was best expressed by Higuchi model as the results shows high linearity. The results also proved CMC sodium to be the best retarding material than HPC and HPMC, hence concluded that sustained release matrices of Levosulpiride can be prepared using CMC Sodium, HPC and HPMC as carriers.

Authors and Affiliations

Dr. Muhammad Samie

Keywords

Related Articles

CYTOTOXICITY EVALUATIONS OF THE AQUEOUS EXTRACTS OF HERBAL MELANIN DRIVED FROM NIGELLA SATIVA SEEDS USING IN VIVO AND IN VITRO MODELS TESTS

Background: Many studies over millennia have been carried out to determine a widely used medicinal plant throughout the world. Of these, most of the therapeutic properties of Nigella sativa (N. sativa) seeds are due to t...

DEVELOPMENT OF A NEW CHROMATOGRAPHIC METHOD FOR ESTIMATION OF DOLASETRON IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC

Background: A simple, accurate and precise HPLC method for simultaneous determination of Dolasetron in pure and tablet dosage form has been developed. Aim: Development Of A New Chromatographic Method For Estimation Of Do...

DIABETES: QUANTUM ANALYSIS OF THE INTERACTIONS OF CARNOSINE AND OTHER DIPEPTIDES VS. GLUCOSE

The treatments with carnosine and other peptides have revolutionized science in recent years. Researchers show that treatment with carnosine improves glucose (GLU) metabolism, albuminuria, and pathology. The objective of...

GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME (GLUT1) AND USING KETOGENIC DIET IN TREATMENT OF DE VIVO DISEASE (A CASE REPORTS).

We present experience of ketogenic diet (KD) applying in the treatment of pharmacoresistant epilepsy in a patients with glucose transporter deficiency syndrome type I (GLUT1). We observed six children with refractory epi...

PREPARATION AND IDENTIFICATION OF COMPLEXES IONS CU(II) AND CO(II) , WITH NEW LIGAND [4-[N-(5-METHYL ISOXAZOL-3-YL) BENZENE SULFONAMIDE AZO] - 5- NITRO-4- PHENYL IMIDAZOL]

The new ligand of 4-[N-(5-methyl isoxazol-3-yl) benzene sulfonamide azo] - 5- nitro-4-phenyl imidazol is presented in this research paper . Three chelate compounds are as well arranged through this ligand reaction with C...

Download PDF file
  • EP ID EP617280
  • DOI -
  • Views 180
  • Downloads 0

How To Cite

Dr. Muhammad Samie (2017). DESIGN, FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE TABLET FORMULATIONS OF LEVOSULPIRIDE. World Journal of Pharmaceutical Research, 6(3), 68-86. https://europub.co.uk/articles/-A-617280